Copilot
Your everyday AI companion
About 10.400 results
Open links in new tab
  1. AstraZeneca US
    https://www.astrazeneca-us.com/media/press-releases/2024/ultomiris...

    ULTOMIRIS® (ravulizumab-cwvz) approved in the US for the …

    ULTOMIRIS ® (ravulizumab-cwvz), the first and only long-acting C5 complement inhibitor, provides immediate, complete and sustained complement inhibition. The medication works by inhibiting the C5 protein in the terminal complement cascade, a part of the body’s immune system.
    Feedback
  2. ULTOMIRIS REMS
    https://ultomirisrems.com

    ULTOMIRIS

  3. Images of Ultomiris Pi

    bing.com/images
    See all images
  4. AstraZeneca
    https://www.astrazeneca.com/media-centre/press-releases/2024/ultomiris...

    Ultomiris approved in the US for the treatment of adults with ...

  5. Drugs.com
    https://www.drugs.com/dosage/ultomiris.html

    Ultomiris Dosage Guide - Drugs.com

  6. People also ask
    What is Ultomiris (Ravulizumab-cwvz)?
    Ultomiris (ravulizumab-cwvz) has been approved in the United States (US) as the first and only long-acting C5 complement inhibitor for the treatment of adult patients with anti-aquaporin-4 (AQP4) antibody-positive (Ab+) neuromyelitis optica spectrum disorder (NMOSD). 1

    Ultomiris approved in the US for the treatment of adults with

    astrazeneca.com
    Is Ultomiris indicated for patients with atypical hemolytic uremic syndrome?
    ULTOMIRIS is indicated for the treatment of adult and pediatric patients one month of age and older with atypical hemolytic uremic syndrome (aHUS) to inhibit complement-mediated thrombotic microangiopathy (TMA). ULTOMIRIS is not indicated for the treatment of patients with Shiga toxin E. coli related hemolytic uremic syndrome (STEC-HUS).

    Ultomiris (Alexion Pharmaceuticals Inc.): FDA Package Insert

    medlibrary.org
    What is Ultomiris used for?
    INDICATION (S) What is ULTOMIRIS? ULTOMIRIS is a prescription medicine used to treat: adults and children 1 month of age and older with a disease called Paroxysmal Nocturnal Hemoglobinuria (PNH). adults and children 1 month of age and older with a disease called atypical Hemolytic Uremic Syndrome (aHUS).

    ULTOMIRIS® (ravulizumab-cwvz) approved in the US for the treatment of

    astrazeneca-us.com
    Can Ultomiris cause a life threatening infection?
    ULTOMIRIS increases your chance of getting serious meningococcal infections that may quickly become life-threatening or cause death if not recognized and treated early. You must complete or update meningococcal vaccine (s) at least 2 weeks before your first dose of ULTOMIRIS.

    ULTOMIRIS® (ravulizumab-cwvz) approved in the US for the treatment of

    astrazeneca-us.com
    Feedback
  7. MedLibrary.org
    https://medlibrary.org/lib/rx/meds/ultomiris

    Ultomiris (Alexion Pharmaceuticals Inc.): FDA Package Insert

  8. medicines.org.uk
    https://www.medicines.org.uk/emc/product/11944

    Ultomiris 300 mg/3 mL concentrate for solution for infusion

  9. Drugs.com
    https://www.drugs.com/pro/soliris.html

    Soliris: Package Insert - Drugs.com

    WEBApr 15, 2024 · SOLIRIS, a complement inhibitor, increases a patient's susceptibility to serious, life-threatening, or fatal infections caused by meningococcal bacteria (septicemia and/or meningitis) in any …

  10. MedicineNet
    https://www.medicinenet.com/ultomiris_ravulizumab/article.htm

    Ultomiris: PNH Uses, Side Effects, Dosage - MedicineNet

  11. pharmaphorum
    https://pharmaphorum.com/news/second-ask-fda-clears-azs-ultomiris-nm…

    At second ask, FDA clears AZ’s Ultomiris for NMOSD

  12. MPR
    https://www.empr.com/home/news/fda-approves-ultomiris-for...

    FDA Approves Ultomiris for Neuromyelitis Optica Spectrum Disorder